Ariston Services Group Boosts Stock Position in UnitedHealth Group Incorporated $UNH

Ariston Services Group grew its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 13.6% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 953 shares of the healthcare conglomerate’s stock after purchasing an additional 114 shares during the period. Ariston Services Group’s holdings in UnitedHealth Group were worth $297,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the company. Nabity Jensen Investment Management Inc boosted its holdings in shares of UnitedHealth Group by 0.9% in the first quarter. Nabity Jensen Investment Management Inc now owns 2,760 shares of the healthcare conglomerate’s stock valued at $1,446,000 after acquiring an additional 24 shares in the last quarter. Atlantic Edge Private Wealth Management LLC boosted its holdings in UnitedHealth Group by 8.9% in the 1st quarter. Atlantic Edge Private Wealth Management LLC now owns 305 shares of the healthcare conglomerate’s stock valued at $160,000 after purchasing an additional 25 shares in the last quarter. Osborne Partners Capital Management LLC raised its stake in shares of UnitedHealth Group by 2.5% during the 1st quarter. Osborne Partners Capital Management LLC now owns 1,066 shares of the healthcare conglomerate’s stock worth $558,000 after buying an additional 26 shares in the last quarter. HHM Wealth Advisors LLC boosted its stake in shares of UnitedHealth Group by 0.9% in the first quarter. HHM Wealth Advisors LLC now owns 2,947 shares of the healthcare conglomerate’s stock valued at $1,544,000 after buying an additional 26 shares in the last quarter. Finally, MPS Loria Financial Planners LLC raised its position in UnitedHealth Group by 0.4% in the first quarter. MPS Loria Financial Planners LLC now owns 7,256 shares of the healthcare conglomerate’s stock worth $3,800,000 after acquiring an additional 27 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on UNH shares. The Goldman Sachs Group started coverage on shares of UnitedHealth Group in a research note on Tuesday. They set a “buy” rating and a $406.00 price target on the stock. Weiss Ratings reiterated a “sell (d+)” rating on shares of UnitedHealth Group in a research report on Wednesday, October 8th. Barclays raised their price objective on UnitedHealth Group from $352.00 to $386.00 and gave the company an “overweight” rating in a research note on Thursday, October 9th. KeyCorp upped their target price on UnitedHealth Group from $350.00 to $400.00 and gave the company an “overweight” rating in a report on Wednesday, October 8th. Finally, Royal Bank Of Canada cut their price target on UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating for the company in a research note on Wednesday, July 30th. Eighteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have issued a Sell rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Hold” and a consensus target price of $385.13.

UnitedHealth Group Stock Performance

NYSE UNH opened at $356.53 on Friday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The company has a market capitalization of $322.90 billion, a PE ratio of 15.45, a price-to-earnings-growth ratio of 2.31 and a beta of 0.47. The business’s 50-day moving average price is $329.38 and its 200 day moving average price is $344.86. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company had revenue of $111.62 billion during the quarter, compared to analysts’ expectations of $111.75 billion. During the same quarter in the previous year, the firm posted $6.80 earnings per share. UnitedHealth Group’s revenue for the quarter was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were issued a dividend of $2.21 per share. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. UnitedHealth Group’s payout ratio is presently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.